Neurocrine Biosciences | NBIX - Ebitda

Harga Saham
131.87
Perubahan Harian
0.27 0.21%
Bulanan
1.49%
Tahunan
41.42%
Q2 Perkiraan
127.64




Ebitda Perubahan Tanggal
AbbVie USD 3.52B 828M 2025-09
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
ALKERMES USD 100.31M 21.24M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Cytokinetics USD -277.18M 169.36M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Incyte USD 414.5M 92.42M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Pfizer USD 6.08B 351M 2025-09
Prothena USD -39.53M 12.25M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Repligen USD 39.54M 3.61M 2025-12
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09
Xoma USD 2.52M 7.98M 2024-06